New Jersey Administrative Code
Title 13 - LAW AND PUBLIC SAFETY
Chapter 39 - STATE BOARD OF PHARMACY
Subchapter 11B - COMPOUNDING ANTINEOPLASTIC AGENTS AND OTHER HAZARDOUS SUBSTANCES: STERILE AND NON-STERILE PREPARATIONS
Section 13:39-11B.1 - Purpose and scope

Universal Citation: NJ Admin Code 13:39-11B.1

Current through Register Vol. 56, No. 6, March 18, 2024

(a) The rules in this subchapter regulate the practice of compounding antineoplastic agents and other hazardous substances for both sterile and non-sterile preparations and shall apply to all retail and institutional pharmacies that compound and dispense antineoplastic agents and other hazardous substances. The rules in this subchapter supplement those of N.J.A.C. 13:39-11 and 11A. To the extent the requirements for compounding antineoplastic agents and other hazardous substances are not specifically addressed in this subchapter, the requirements of N.J.A.C. 13:39-11 and 11A, as applicable, shall be followed.

(b) Effective on the effective date of USP 800 (currently, December 1, 2019), the compounding of antineoplastic agents and other hazardous substances shall be consistent with the standards established in USP 800, which is incorporated herein by reference, as amended and supplemented, and which is available for purchase at the United States Pharmacopeia website, www.usp.org.

Disclaimer: These regulations may not be the most recent version. New Jersey may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.